Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation

Clinical Genetics

Volumn 86, Issue 2, 2014, Pages 181-184

  Summers, S M ^a,b   Cogswell, J ^a,b   Goodrich, J E ^a,b   Mu, Y ^b   Nguyen, D V ^c   Brass, S D ^b   Hagerman, R J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fragile X premutation; Insomnia; Restless legs syndrome; Sleep; Trinucleotide repeat disorders

Indexed keywords

ADULT; AGED; ARTICLE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; FRAGILE X SYNDROME; HEALTH SURVEY; HETEROZYGOTE; HUMAN; INSOMNIA SEVERITY INDEX; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RESEARCH DIAGNOSTIC CRITERIA; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SLEEP QUALITY; AGE; CASE CONTROL STUDY; DEMOGRAPHY; GENETICS; INSOMNIA; MUTATION; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SLEEP;

FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN;

AGE FACTORS; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84904657803     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12249     Document Type: Article

References (19)

1. Tassone F, Iong KP, Tong TH et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 2012: 4: 100.
2. Fu Y-H, Kuhl DPA, Pizzuti A et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991: 67: 1047-1058.
3. Pieretti M, Zhang FP, Fu YH et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991: 66: 817-822.
4. Harvey J, Judge C, Wiener S. Familial X-linked mental retardation with an X chromosome abnormality. J Med Genet 1977: 14: 46-50.
5. Hagerman RJ, Leehey M, Heinrichs W et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001: 57: 127-130.
6. Sellier C, Freyermuth F, Tabet R et al. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 2013: 3: 869-880.
7. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord 2007: 22: S440-S448.
8. Napoli E, Ross-Inta C, Wong S et al. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet 2011: 20: 3079-3092.
9. Abele M, Burk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol 2001: 248: 311-314.
10. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002: 59: 421-424.
11. Allen RP, Picchietti D, Hening WA et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003: 4: 101-119.
12. Walters AS, LeBrocq C, Dhar A et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003: 4: 121-132.
13. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991: 14: 540-545.
14. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001: 2: 297-307.
15. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989: 28: 193-213.
16. Eisensehr I, Wetter TC, Linke R et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001: 57: 1307-1309.
17. Wang H, Wu LJ, Kim SS et al. FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 2008: 59: 634-647.
18. Fulda S, Wetter TC. Is daytime sleepiness a neglected problem in patients with restless legs syndrome? Mov Disord 2007: 22: S409-S413.
19. Cuellar NG, Strumpf NE, Ratcliffe SJ. Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life. J Am Geriatr Soc 2007: 55: 1387-1392.